Sun Pharma fails to stop Intas Pharmaceuticals from using the mark SITARA-D/SITARE for Sitagliptin
Pharma branding is difficult terrain. The inspiration for a brand name in the pharmaceutical field is often drawn from the pharmaceutical ingredient or ailment the product intends to cure. Thus, it is challenging to stop third parties from adopting the portion of the brand derived from drug composition or an International Non-Proprietary name (INN). The…